Listed

Modular Medical, Inc.: Form 10-Q for the period ended Dec 31, 2022

Filed with the SEC on Feb 13, 2023 and accepted by EDGAR at Feb 13, 2023, 17:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2022-10-01 to 2022-12-31$2.2mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2022-04-01 to 2022-12-31$6.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-10-01 to 2022-12-31−$3.4mus-gaap:OperatingIncomeLoss
Operating income9 months2022-04-01 to 2022-12-31−$10.3mus-gaap:OperatingIncomeLoss
Income tax9 months2022-04-01 to 2022-12-31$1.6kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-10-01 to 2022-12-31−$3.4mus-gaap:NetIncomeLoss
Net income9 months2022-04-01 to 2022-12-31−$10.3mus-gaap:NetIncomeLoss
Operating cash flow9 months2022-04-01 to 2022-12-31−$8.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-04-01 to 2022-12-31$573.1kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-12-31$7.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-12-31$8.0mus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$8.7mus-gaap:Assets
Current liabilitiesAt period end2022-12-31$715.3kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$715.3kus-gaap:Liabilities
Shareholders' equityAt period end2022-12-31$8.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001019056-23-000132. Last ingested by Listed: Nov 6, 2026, 13:29 ET. Listed shows no prices and gives no investment advice.